VERTEX PHARMAC. DL-,01 earnings per share and revenue

VX1 earnings per share for the last quarter are 3.81 EUR whereas the estimation was 3.68 EUR which accounts for 3.27% surprise. Company revenue for the same period amounts to 2.28 B EUR despite the estimated figure of 2.28 B EUR. Estimated earnings per share for the next quarter are 3.78 EUR, and revenue is expected to reach 2.39 B EUR. Also watch annual changes over time to get a bigger picture of VX1 earnings per share and revenue dynamics.